PRNP contains both intronic and upstream regulatory regions that may influence susceptibility to Creutzfeldt-Jakob Disease

被引:41
作者
McCormack, JE
Baybutt, HN
Everington, D
Will, RG
Ironside, JW
Manson, JC
机构
[1] Inst Anim Hlth, Neuropathogenesis Unit, Edinburgh EH9 3JF, Midlothian, Scotland
[2] Natl CJD Surveillance Unit, Edinburgh, Midlothian, Scotland
基金
英国医学研究理事会; 英国惠康基金; 英国生物技术与生命科学研究理事会;
关键词
Prion disease; transmissible spongiform encephalopathies; Prion protein;
D O I
10.1016/S0378-1119(02)00466-3
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The Prion protein (PrP) plays a central role in Creutzfeldt-Jakob Disease (CJD) and other transmissible spongiform encephalopathies (TSEs). Mutations in the protein coding region of the human PrP gene (PRNP), which have been proposed to alter the stability of the PrP protein, have been linked to a number of forms of TSE. However, the majority of CJD cases are not associated with mutations in the PRNP coding region and alternative mechanisms must therefore underlie susceptibility to these forms of CJD. Transgenic mice, that over- or under-express PrP genes, have shown a correlation between the level of PrP gene expression and the incubation time of disease. Polymorphisms that lead to alterations in human PRNP gene expression, could therefore be candidates for influencing susceptibility of an individual to CJD. In order to investigate this hypothesis, we have defined an upstream and intronic regulatory region of the PRNP gene. Sequencing of these regions in controls, sporadic CID (sCJD) and variant CJD (vCJD) patients has identified three polymorphisms, all of which are more common in sCJD patients than controls. Our data suggests that polymorphisms in the regulatory region of the PRNP gene may be a risk factor for CID. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:139 / 146
页数:8
相关论文
共 27 条
[1]   Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease [J].
Alperovitch, A ;
Zerr, I ;
Pocchiari, M ;
Mitrova, E ;
Cuesta, JD ;
Hegyi, I ;
Collins, S ;
Kretzschmar, H ;
van Duijn, C ;
Will, RG .
LANCET, 1999, 353 (9165) :1673-1674
[2]  
[Anonymous], 1990, GENETIC DATA ANAL
[3]   Characterisation of two promoters for prion protein (PrP) gene expression in neuronal cells [J].
Baybutt, H ;
Manson, J .
GENE, 1997, 184 (01) :125-131
[4]   Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent [J].
Bruce, ME ;
Will, RG ;
Ironside, JW ;
McConnell, I ;
Drummond, D ;
Suttie, A ;
McCardle, L ;
Chree, A ;
Hope, J ;
Birkett, C ;
Cousens, S ;
Fraser, H ;
Bostock, CJ .
NATURE, 1997, 389 (6650) :498-501
[5]   MICE DEVOID OF PRP ARE RESISTANT TO SCRAPIE [J].
BUELER, H ;
AGUZZI, A ;
SAILER, A ;
GREINER, RA ;
AUTENRIED, P ;
AGUET, M ;
WEISSMANN, C .
CELL, 1993, 73 (07) :1339-1347
[6]   Prion protein and the transmissible spongiform encephalopathy diseases [J].
Chesebro, B .
NEURON, 1999, 24 (03) :503-506
[7]  
d'Aignaux JH, 1998, AM J EPIDEMIOL, V147, P597
[8]   Functional characterization of the human prion protein promoter in neuronal and endothelial cells [J].
Funke-Kaiser, H ;
Theis, S ;
Behrouzi, T ;
Thomas, A ;
Scheuch, K ;
Zollmann, FS ;
Paterka, M ;
Paul, M ;
Orzechowski, HD .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2001, 79 (09) :529-535
[9]   The same prion strain causes vCJD and BSE [J].
Hill, AF ;
Desbruslais, M ;
Joiner, S ;
Sidle, KCL ;
Gowland, I ;
Collinge, J ;
Doey, LJ ;
Lantos, P .
NATURE, 1997, 389 (6650) :448-450
[10]   Characterization of the bovine prion protein gene: The expression requires interaction between the promoter and intron [J].
Inoue, S ;
Tanaka, M ;
Horiuchi, M ;
Ishiguro, N ;
Shinagawa, M .
JOURNAL OF VETERINARY MEDICAL SCIENCE, 1997, 59 (03) :175-183